Devastating Ruling Threatens Access to Essential Reproductive Care and Entire U.S. Drug Approval Process
Washington DC — Today, Judge Matthew Kacsmaryk issued a ruling to pull mifepristone from the market. Mifepristone is a safe and effective medication that is essential to abortion access across the nation. This decision not only threatens access to vital reproductive care for millions of women, but it opens the door for the politically-motivated destruction of the entire drug approval process. In response, Protect Our Care Chair Leslie Dach issued the following statement:
“Today’s decision is a disaster for the American people. We are talking about a right-wing judge overruling the opinion of top scientists and other medical experts at the FDA. Taking away a safe, effective medication for abortion is dangerous, especially for rural women, people of color, and other vulnerable groups. This decision also means that judges now have the power to rip away other medications at the whim of their political motivations. This ruling must not stand.”